Capitol Health logo

CAJ - Capitol Health Share Price

A$0.345 -0.0  -1.4%

Last Trade - 5:10am

Small Cap
Market Cap £201.7m
Enterprise Value £238.6m
Revenue £86.7m
Position in Universe 475th / 1835
Unlock CAJ Revenue
Relative Strength (%)
1m +22.0%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High 0.000
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
110.8 104.5 107.5 119.5 149.2 153.8 170.1 192.1 +6.8%
-2.2 -68.3 +14.8 -64.4 +503.3 -70.5 +163.9 +60.0
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 30 June 2020, CapitolHealth Ltd revenues increased 3% to A$153.8M. Net incomedecreased 96% to A$865K. Revenues reflect Other operatingrevenue increase of 80% to A$184K. Net income was offset byRevaluation/(impairment) of financial as increase fromA$19.9M (income) to A$1.6M (expense), Dep of Fin LeaseRight-of-Use Assets increase from A$0K to A$8.6M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


CAJ Revenue Unlock CAJ Revenue

Net Income

CAJ Net Income Unlock CAJ Revenue

Normalised EPS

CAJ Normalised EPS Unlock CAJ Revenue

PE Ratio Range

CAJ PE Ratio Range Unlock CAJ Revenue

Dividend Yield Range

CAJ Dividend Yield Range Unlock CAJ Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CAJ EPS Forecasts Unlock CAJ Revenue
Profile Summary

Capitol Health Limited is a provider of diagnostic imaging and related services to the Australian healthcare market. The Company owns and operates clinics throughout Victoria and New South Wales. It is engaged in the acquisition and operation of diagnostic imaging facilities. Trading primarily under its brand Capital Radiology, the Company provides a range of diagnostic imaging services. The Company's services include general X-ray; magnetic resonance imaging (MRI); ultrasound; mammography; Doppler; orthopantomography (OPG); echocardiography; computer tomography (CT); CT Angiography; nuclear medicine; bone densitometry, and fluoroscopy. The Company conducts over one million procedures every year. The Company focuses on delivering a community-based infrastructure for radiologists and related medical practitioners.

Last Annual June 30th, 2020
Last Interim June 30th, 2020
Incorporated December 1, 2005
Public Since June 9, 2006
No. of Shareholders: 5,462
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Providers & Services
Index S&P/ASX All Ordinaries ,
Exchange Australian Stock Exchange - SEATS
Shares in Issue 1,022,597,194
Free Float (0.0%)
Eligible for
CAJ Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for CAJ
Upcoming Events for CAJ
Frequently Asked Questions for Capitol Health
What is the Capitol Health share price?

As of 5:10am, shares in Capitol Health are trading at A$0.345, giving the company a market capitalisation of £201.7m. This share price information is delayed by 15 minutes.

How has the Capitol Health share price performed this year?

Shares in Capitol Health are currently trading at A$0.345 and the price has moved by 20.69% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Capitol Health price has moved by 15.34% over the past year.

What are the analyst and broker recommendations for Capitol Health?

Of the analysts with advisory recommendations for Capitol Health, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Capitol Health is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Capitol Health next release its financial results?

Capitol Health is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Capitol Health dividend yield?

The Capitol Health dividend yield is 2.43% based on the trailing twelve month period.

Does Capitol Health pay a dividend?

Last year, Capitol Health paid a total dividend of 0.01, and it currently has a trailing dividend yield of 2.43%. Looking ahead, shares in Capitol Health are due to go ex-dividend on 2021-03-04 and the next dividend pay date is 2021-04-01.

When does Capitol Health next pay dividends?

Capitol Health are due to go ex-dividend on 2021-03-04 and the next dividend pay date is 2021-04-01. The historic dividend yield on Capitol Health shares is currently 2.43%.

How do I buy Capitol Health shares?

To buy shares in Capitol Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Capitol Health?

Shares in Capitol Health are currently trading at A$0.345, giving the company a market capitalisation of £201.7m.

Where are Capitol Health shares listed? Where are Capitol Health shares listed?

Here are the trading details for Capitol Health:

Country of listing: Australia
Exchange: ASX
Ticker Symbol: CAJ
What kind of share is Capitol Health?

Based on an overall assessment of its quality, value and momentum, Capitol Health is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Capitol Health share price forecast 2021?

Shares in Capitol Health are currently priced at A$0.345. At that level they are trading at 6.29% premium to the analyst consensus target price of 0.00.

Analysts covering Capitol Health currently have a consensus Earnings Per Share (EPS) forecast of 0.01 for the next financial year.

How can I tell whether the Capitol Health share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Capitol Health. Over the past six months, the relative strength of its shares against the market has been 23.06%. At the current price of A$0.345, shares in Capitol Health are trading at 39.69% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Capitol Health PE Ratio?

The Capitol Health PE ratio based on its reported earnings over the past 12 months is 92.35. The shares are currently trading at A$0.345.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Capitol Health?

Capitol Health's management team is headed by:

Andrew Demetriou - NEC
Nicole Sheffield - NID
Richard Loveridge - NID
Melanie Leydin - SEC
Justin Walter - CEO
Craig Bremner - CFO
Who are the major shareholders of Capitol Health?

Here are the top five shareholders of Capitol Health based on the size of their shareholding:

Challenger Managed Investments Ltd. Investment Advisor
Percentage owned: 10.04% (103.2m shares)
Lennox Capital Partners Pty Ltd. Investment Advisor
Percentage owned: 6.6% (67.8m shares)
Paradice Investment Management Pty. Ltd. Investment Advisor
Percentage owned: 6.56% (67.4m shares)
Wilson Asset Management (International) Pty. Ltd. Investment Advisor
Percentage owned: 5.58% (57.4m shares)
ICE Investors Pty., Ltd. Investment Advisor
Percentage owned: 4.04% (41.5m shares)
Similar to CAJ
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.